Kansas Gov. Sebelius Signs Bill Requiring Providers To Offer Ultrasounds Prior To Abortions

Kansas Gov. Kathleen Sebelius (D), President Obama’s nominee for HHS secretary, on Friday signed a bill (S.B. 238) that requires abortion providers to offer women seeking abortions the option of viewing an ultrasound and listening to a fetal heartbeat monitor, the

Self Magazine Examines Issues Related To Multifetal Reductions After Fertility Treatments

Self magazine in its April 2009 issue examines issues surrounding multifetal reduction, a procedure used to reduce the number of fetuses in pregnancies with triplets or more, typically as a result of infertility treatments.

Sec. Of State Clinton Says Reproductive Rights Important In U.S. Foreign Policy

Secretary of State Hillary Rodham Clinton on Friday said that women’s reproductive health and rights are key issues in the Obama administration’s foreign policy and important parts of U.S. efforts to develop democracy abroad, the AP/Houston Chronicle reports. Speaking at the

Proposed Changes To U.K. Advertising Code Would Loosen Restrictions On Abortion, Condom Ads

British regulators on Thursday proposed changing the country’s advertising rules to allow organizations that provide abortion advice and referrals to run television and radio ads for the first time, the AP/Google.com reports. The proposal is part of a larger review of the country’s advertising rules and is subject to public review and the approval of [...]

FDA: Don’t Eat Pistachios Till Salmonella Source Found

WASHINGTON (MedPage Today) — The FDA is warning Americans not to eat pistachio products until it locates a million pounds of roasted nuts from a California producer that may be contaminated with salmonella.

Takeda To Create Global Centers Of Excellence

Takeda Pharmaceutical Company Limited (”Takeda”) announced a reorganization of its corporate structure, as part of its 2006-2010 Medium-Term Plan vision to become a global pharmaceutical company with highly integrated global operations.

Intercell Announces FDA Approval Of IXIARO(R), A Novel Vaccine To Prevent Japanese Encephalitis

Intercell AG (VSE: ICLL) announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE). The initial target for use of Intercell’s vaccine - the only such product currently manufactured for the U.S. market - will be adult travelers and military personnel who visit or [...]

Schering-Plough Announces Results Of The Early ACS Trial

In a study presented at the 58th annual Scientific Sessions of the American College of Cardiology and simultaneously published by The New England Journal of Medicine, researchers reported that a strategy using an upstream, investigational dose of INTEGRILIN(R) (eptifibatide) routinely in patients with Acute Coronary Syndrome (ACS), at least 12 hours prior to angiography, failed [...]

CERVARIX(R) U.S. Regulatory Update

GlaxoSmithKline (NYSE: GSK) provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of CERVARIX(R), its vaccine to prevent cervical cancer and cervical pre-cancer related to human papillomavirus types 16 and 18. GSK has submitted final data from its Phase III pivotal efficacy study, [...]

Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy And Safety Endpoints

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced positive top-line results from BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management), the first of two pivotal trials evaluating the safety and efficacy of lorcaserin for weight management. Statistical significance (p